Clinical Trials
39 trialsNCT00003479 2022-02-23
Antineoplaston Therapy in Treating Patients With Ependymoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003511 2021-06-09
Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Burzynski Research Institute
Phase 2 Terminated
NCT00003487 2021-05-14
Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Burzynski Research Institute
Phase 2 Terminated
NCT00003508 2021-04-27
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003498 2021-01-22
Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003531 2021-01-07
Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003509 2020-12-19
Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003526 2020-12-17
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Burzynski Research Institute
Phase 2 Terminated
NCT00003492 2020-12-16
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003453 2018-05-09
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003471 2018-03-22
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003472 2018-03-21
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003535 2018-03-21
Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003497 2018-02-05
Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003500 2018-02-05
Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003501 2018-02-05
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003516 2018-02-05
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003494 2018-01-31
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003532 2017-12-12
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003533 2017-12-12
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003530 2017-11-21
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003491 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003515 2017-09-29
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
Burzynski Research Institute
Phase 2 Terminated
NCT00003520 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003521 2017-09-29
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003522 2017-09-29
Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Burzynski Research Institute
Phase 2 Terminated
NCT00003524 2017-09-29
Antineoplaston Therapy in Treating Patients With Stomach Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003525 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Burzynski Research Institute
Phase 2 Terminated
NCT00003452 2017-09-28
Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder
Burzynski Research Institute
Phase 2 Terminated
NCT00003454 2017-09-28
Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003485 2017-09-28
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003495 2017-09-28
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003496 2017-09-28
Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003513 2017-09-28
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003469 2017-08-24
Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Burzynski Research Institute
Phase 2 Terminated
NCT00003476 2017-08-24
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Burzynski Research Institute
Phase 2 Terminated
NCT00003483 2017-08-24
Antineoplaston Therapy in Treating Patients With Meningioma
Burzynski Research Institute
Phase 2 Terminated
NCT02988726 2017-07-26
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Burzynski Research Institute
Phase 2 Terminated